Anatomy of a rescue: Heroic strangers save Surrey family from mudslide
The family's car rolled down a ravine, leaving a teenage son with bad head injuries. They are now recovering and grateful to their rescuers.
Stay updated with breaking news from Greg Haljan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The family's car rolled down a ravine, leaving a teenage son with bad head injuries. They are now recovering and grateful to their rescuers.
A day in the life of Surrey Memorial's critical care unit, which has treated nearly half of B.C.'s COVID ICU patients.
VANCOUVER -- Declining COVID-19 case numbers have given many British Columbians hope for the summer. The province has promised if specific targets are met, residents could soon enjoy much more freedom. But for the professionals working tirelessly inside Surrey Memorial Hospital’s COVID-19 intensive care unit, the fight is far from over. "I think it'll be pretty overwhelming when you sit and reflect on everything that's gone on because we've seen a lot, it's been very traumatic," says Manjot Kaur, an ICU Nurse. "We have to tough it through because it’s our job and we want to help." ...
TORONTO -- At a clinic in Surrey, B.C., some newly diagnosed COVID-19 patients are receiving a therapy that few other Canadians can get. The Canadian-made treatment is called bamlanivimab, and it involves infusing patients with monoclonal antibodies within three days of testing positive, all with the aim of preventing their illness from progressing into life-threatening. Bamlanivimab has been approved and used around the world in more than 400,000 patients, but the treatment is contentious due to recent concerns from the FDA and Health Canada regarding its effectiveness. But despite c...
VANCOUVER -- The head of a Vancouver-based biotech company says he’s frustrated at the delay in delivering what he calls a potentially "life-saving" COVID-19 treatment. Carl Hansen is the CEO of AbCellera, which discovered an antibody treatment for the virus last year. In partnership with Eli Lilly Canada, the two companies developed the drug bamlanivimab. It was first approved for emergency use by Health Canada in November, shortly after FDA approval in the U.S. Since then, Hansen says nearly half a million people over the border have been treated with the drug, but that’s not the...